NovoCure (NVCR) Total Non-Current Liabilities (2016 - 2025)
Historic Total Non-Current Liabilities for NovoCure (NVCR) over the last 12 years, with Q3 2025 value amounting to $243.9 million.
- NovoCure's Total Non-Current Liabilities rose 9322.44% to $243.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $243.9 million, marking a year-over-year increase of 9322.44%. This contributed to the annual value of $124.2 million for FY2024, which is 7944.99% down from last year.
- NovoCure's Total Non-Current Liabilities amounted to $243.9 million in Q3 2025, which was up 9322.44% from $146.8 million recorded in Q2 2025.
- NovoCure's Total Non-Current Liabilities' 5-year high stood at $681.2 million during Q2 2024, with a 5-year trough of $124.2 million in Q4 2024.
- For the 5-year period, NovoCure's Total Non-Current Liabilities averaged around $481.2 million, with its median value being $586.4 million (2021).
- Per our database at Business Quant, NovoCure's Total Non-Current Liabilities skyrocketed by 193201.06% in 2021 and then crashed by 7944.99% in 2024.
- Quarter analysis of 5 years shows NovoCure's Total Non-Current Liabilities stood at $586.4 million in 2021, then increased by 0.9% to $591.7 million in 2022, then rose by 2.17% to $604.5 million in 2023, then plummeted by 79.45% to $124.2 million in 2024, then skyrocketed by 96.29% to $243.9 million in 2025.
- Its Total Non-Current Liabilities stands at $243.9 million for Q3 2025, versus $146.8 million for Q2 2025 and $143.5 million for Q1 2025.